Research programme: regenerative therapies - Summit
Alternative Names: Small molecule stem cell modulators - SummitLatest Information Update: 16 Jul 2016
Price :
$50 *
At a glance
- Originator MRC Functional Genetics Unit; University of Oxford; VASTox; Weatherall Institute of Molecular Medicine
- Class Small molecules
- Mechanism of Action Stem cell stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Inflammatory bowel diseases; Parkinson's disease
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in United Kingdom
- 16 Jul 2016 No recent reports of development identified for preclinical development in Inflammatory-bowel-disease in United Kingdom
- 16 Jul 2016 No recent reports of development identified for preclinical development in Parkinson's-disease in United Kingdom